The D-Lightful Vitamin D for Health / Vitamin D Za Dobro Zdravlje

Open access


Vitamin D is the sunshine vitamin that is not only important for children’s and adults’ skeletal health but is also important for their overall health and wellbeing. Vitamin D deficiency has been defined as a 25-hydroxyvitamin D < 20 ng/mL and vitamin D insufficiency as a 25-hydroxyvitamin D of 21-29 ng/mL. The major source of vitamin D is sensible sun exposure since very few foods naturally contain vitamin D. Vitamin D deficiency is associated with in - creased risk for many acute and chronic diseases including infectious diseases, autoimmune diseases, cardiovascular disease, type 2 diabetes, neurocognitive dysfunction and muscle weakness. To achieve a blood level of 25-hydroxy - vitamin D >30 ng/mL children require 600-1 000 IUs and adults 1 500-2 000 IUs of vitamin D daily.

1. Holick M. Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to humans. In: Pang PKT and Schreibman MP, editors. Vertebrate Endocrinology: Fundamentals and Biomedical Implications. Orlando, FL: Academic Press, Inc. (Harcourt Brace Jovanovich), 1989; 3: 7-43.

2. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clinical Invest 2006; 116: 2062-72.

3. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011; 12: 4-18.

4. Hess AF, Unger LJ. The cure of infantile rickets by sunlight. J Am Med Assoc 1921; 77: 39-41.

5. Steenbock H. The induction of growth-prompting and calcifying properties in a ration exposed to light. Science 1924; 60: 224-5.

6. British Pediatric Association. Hypercalcemia in infants and vitamin D. Brit Med J 1956; 2: 149-51.

7. Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357: 266-81.

8. Holick MF. Vitamin D and Health: Evolution, Biologic Funtions, and Recommended Dietary Intakes for Vitamin D. Clin Rev Bone Miner Metab 2009; 7(1): 2-19.

9. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61: 638S-645S.

10. Biancuzzo RM, Cai MH, Winter MR, Klein EK, Ameri A, Reitz R, Salameh W, Young A, Bibuld D, Chen TC, Holick MF. Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults. Am J Clin Nutr 2010; 91: 1621-6.

11. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, Reitz R, Salameh W, Ameri A, Tannen baum AD. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93(3): 677-81.

12. Gordon CM, Williams AL, Feldman HA, May J, Sinclair L, Vasquez A, Cox JE. Treatment of hypovitaminosis D in infants and toddlers. J Clin Endocrinol Metab 2008; 93(7): 2716-21.

13. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011; 1-8.

14. Marwaha RK, Tandon N, Reddy D, Aggarwal R, Singh R, Sawhney RC, Saluja B, Ganie M, Singh S. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr 2005; 82: 477-82.

15. Sachan A, Gupta R, Das V, Agarwal A, Awasthi PK, Bhatia V. High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India. Am J Clin Nutr 2005; 81: 1060-4.

16. Rich-Edwards JW, Davaasambuu G, Kleinman K, Sumberzul N, Holick MF, Lkhagvasuren T, Dulguun B, Burke A, Frazier AL. Randomized trial of fortified milk and supplements to raise 25-hydroxyvitamin D concentrations in schoolchildren in Mongolia. Am J Clin Nutr 2011; 94: 578-84.

17. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev 2008; 66: S153-S164.

18. Prentice A, Schoenmakers I, Jones K, Jarjou L, Gold berg G. Vitamin D Deficiency and Its Health Con se quences in Africa. Clin Rev Bone Miner Metab 2009; 7: 94-106.

19. Van der Mei IA, Ponsonby AL, Engelsen O, Pasco JA, McGrath JJ, Eyles DW, Blizzard L, Dwyer T, Lucas R, Jones G. The high prevalence of vitamin D insufficiency across Australian populations is only partly explained by season and latitude. Environ Health Perspect 2007; 115: 1132-9.

20. Maeda SS, Kunii IS, Hayashi L, Lazaretti-Castro M. The effect of sun exposure on 25-hydroxyvitamin D concentrations in young healthy subjects living in the city of Sao Paulo, Brazil. Braz J Med Biol Res 2007; 40: 1653-9.

21. Sedrani SH. Low 25-hydroxyvitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Ann Nutr Metab 1984; 28: 181-5.

22. El-Hajj Fuleihan G. Vitamin D Deficiency in the Middle East and Its Health Consequences. Vitamin D. In Holick, M. F., Ed. Humana Press: 2010; pp 469-94.

23. Rockell J, Skeaff C, Williams S, Green T. Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporos Int 2006; 17: 1382-9.

24. Kumar J, Muntner P, Kaskel FJ, Hailpern SM. Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001-2004. Pediatr 2009; 124(3): e362-e370.

25. Hollis BW. Vitamin D Requirement During Pregnancy and Lactation. J Bone Miner Res 2007; 22: V39-V44.

26. Lee JM, Smith JR, Philipp BL, Chen TC, Mathieu J, Holick MF. Vitamin D deficiency in a healthy group of mothers and newborn infants. Clin Pediatr 2007; 46: 42-4.

27. IOM (Institute of Medicine) 2011. Dietary Reference Intakes for Calcium and Vitamin D. Committee to Review Dietary Reference Intakes for Calcium and Vitamin D. Washington DC: The National Academies Press. Institute of Medicine, 2011.

28. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96(7): 1911-30.

29. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90(6): 3215-24.

30. Thomas KK, Lloyd-Jones DH, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777-83.

31. Chapuy MC, Schott AM, Garnero P, Hans D, Delmas PD, Meunier J, et al. Healthy elderly French women living at home have secondary hyperparathyroidism and high bone turnover in winter. J Clin Endocrinol Metab 1996; 81: 1129-33.

32. Priemel M, Von Domarus C, Klatte TO, Kessler S, Schlie J, Meier S, Proksch N, Pastor F, Netter C, Streichert T, Puschel K, Amling, M. Bone Mine ralization Defects and Vitamin D Deficiency: Histomorphometric Analysis of Iliac Crest Bone Biopsies and Circulating 25-Hydroxyvitamin D in 675 Patients. J Bone Miner Res 2010; 25(2): 305-12.

33. Khosla S, Amin S, Orwoll E. Osteoporosis in Men. Endocr Rev 2008; 29: 441-64.

34. Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007; 24: 1017-29.

35. Garland CF, Garland FC, Shaw EK, Comstock GW, Helsing KJ, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 1989; 18: 1176-8.

36. Garland C, Shekelle RB, Barrett-Connor E, Criqui MH, Rossof AH, Oglesby P. Dietary vitamin D and calcium and risk of colorectal cancer: A 19-year prospective study in men. Lancet 1985; 9: 307-9.

37. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, Holick MF. The role of vitamin D in cancer prevention. Am J Public Health 2006, 96(2): 252-61.

38. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC. Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men. J Natl Cancer Inst 2006; 98(7): 451-9.

39. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and Breast Cancer Risk: The NHANES I Epidemiologic Follow-Up Study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 1999; 8: 399-406.

40. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85(6): 1586-91.

41. Feskanich JM, Fuchs CS, Kirkner GJ, Hankinson SE, Hollis BW, Giovannucci EL. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev 2004; 13(9): 1502-8.

42. Pilz S, Tomaschitz A, Marz W, Drechsler C, Ritz E, Zitterman A, Cavalier E, Pieber TR, Lappe JM, Grant WB, Holick MF, Dekker JM. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol 2011; 75(5): 575-84.

43. Grandi NC, Breitling LP, Brenner H. Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies. Prevent Med 2010; 51: 228-33.

44. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D Deficiency and Supplementation and Relation to Cardiovascular Health. Am J Cardiol 2012; 109: 359-63.

45. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117(4): 503-11.

46. Krause R, Bühring M, Hopfenmüller W, Holick MF, Sharma AM. Ultraviolet B and blood pressure. Lancet 1998; 352: 709-10.

47. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Ster Biochem Molec Biol 2004; 89-90: 387-92.

48. Holick MF. Nutrition: D-iabetes and D-eath D-efying vitamin D. Nat Rev Endocrinol 2012; 8: 388-90.

49. Deleskog A, Hilding A, Brismar K, Hamsten A, Efen dic S, Ostenson CG. Low Serum 25-Hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia 2012; 55(6): 1668-78.

50. Ponsonby AL, McMichael A, Van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002; 181-182: 71-8.

51. Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 2008; 51: 1391-8.

52. Munger KL, Levin LI, Hollis BW, Howard NS, Ascheino A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Am Med Assoc 2006; 296: 2832-8.

53. Sørensen IM, Joner G, Jenum PA, Eskild A, Torjesen PA, Stene LC. Maternal Serum Levels of 25-Hydroxy-Vitamin D During Pregnancy and Risk of Type 1 Diabetes in the Offspring. Diabet 2012; 61: 175-8.

54. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, Gagne D, D'Souza C, Ursell M, O'Connor P. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurol 2010; 74: 1852-9.

55. Pierrot-Deseilligny C, Rivaud-Pechoux S, Clerson P, de Paz R, Souberbielle JC. Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation. Ther Adv Neurol Disord 2012; 5: 187-98.

56. Hypponen E, Laara E, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-3.

57. Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA, Saag KG. Iowa Women’s Health Study. Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis Rheum 2004; 50(1): 72-7.

58. Sabetta JR, DePetrillo P, Cipriani RJ, et al. Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults. Plos One 2010; 5(6): 1-8.

59. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91: 1255-60.

60. Hewison M. An update on vitamin D and human immunity. Clin Endocrinol 2012; 76: 315-25.

61. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008; 87(4): 1080S-6S.

62. Jones G. Expanding role for vitamin D in chronic kidney disease: importance of blood 25-OH-D levels and extrarenal 1alpha-hydroxylase in the classical and nonclassical actions of 1alpha,25-dihydroxyvitamin D3. Seminars in dialysis 2007; 20: 316-24.

63. Fleet JC, Desmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J 2012; 441: 61-76.

64. Blutt SE, McDonnell TJ, Polek TC, Weigel NL. Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-2. Endocrinol 2000; 141: 10-17.

65. Deeb KK, Trump DL, Johnson CS. Vitamin D signaling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7: 684-700.

66. Rohan JNP, Weigel NL. 1a,25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer Cells. Endocrinol 2009; 150: 2046-54.

67. Koli K, Keski-Oja J. 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Diffe rentiation 2000; 11: 221-9.

68. Peña C, García JM, Silva J, García V, Rodríguez R, Alonso I, Millán I, Salas C, de Herreros AG, Muñoz A, Bonilla F. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Molec Gen 2005; 14: 3361-70.

69. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik S, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Sciencexpress 2006; 3: 1770-3.

70. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-87.

71. Pietras SM, Obayan BK, Cai MH, Holick MF. Vitamin D2 treatment for vitamin D deficiency and insufficiency for up to 6 years. Arch Intern Med 2009; 169: 1806-8.

72. Godar DE, Pope SJ, Grant WB, Holick MF. Solar UV Doses of Adult Americans and Vitamin D3 Production. Dermato-Endocrinol 2011; 3(4): 1-8.

73. Kennedy C, Bajdik CD, Willemze R, de Gruijl FR, Bavinck JN. The influence of painful sunburns and lifetime of sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi and skin cancer. J Invest Dermatol 2003; 120(6): 1087-93.

Journal of Medical Biochemistry

The Journal of Society of Medical Biochemists of Serbia

Journal Information

IMPACT FACTOR 2018: 2,000
5-year IMPACT FACTOR: 1,075

CiteScore 2018: 1.47

SCImago Journal Rank (SJR) 2018: 0.523
Source Normalized Impact per Paper (SNIP) 2018: 0.581

Cited By


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 297 248 16
PDF Downloads 152 135 22